|
Synonyms: Lu AG13909 | Lu-AG13909
Compound class:
Antibody
Comment: Asedebart (Lu AG13909) is a humanized monoclonal antibody that binds (neutralizes) human ACTH (corticotropin) by acting as a ligand trap. Peptide matches for the heavy and light chains of asedebart are claimed in patent US10047157B2, and form the antibody named Ab13.H therein [1]. The antibody is intended to block ACTH-mediated activation of melanocortin receptors in the adrenal glands, as a mechanism to reduce the overproduction of cortisol and aldosterone in ACTH‑dependent conditions such as Cushing's disease/syndrome.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13606 | asedebart |
Synonyms ![]() |
| Lu AG13909 | Lu-AG13909 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 1830 |
| Other databases | |
| GtoPdb PubChem SID | 530846918 |
| Search PubMed clinical trials | asedebart |
| Search PubMed titles | asedebart |
| Search PubMed titles/abstracts | asedebart |